Status:
COMPLETED
Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma
Lead Sponsor:
St. Jude Children's Research Hospital
Conditions:
Lymphoblastic Lymphoma
Eligibility:
All Genders
Phase:
NA
Brief Summary
The main purpose of this study is to determine if it is feasible to administer an intensified, multi-agent chemotherapy regimen for children with stage III and IV non-Hodgkin lymphoma and to find out ...
Detailed Description
The overall objective of this research study is to determine the toxicity and feasibility of administration of an intensified, multi-agent chemotherapy regimen for children with stages III and IV non-...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Stage III or IV Lymphoblastic Lymphoma
- One week or less of prior therapy, only to include steroids, vinca alkaloids, and emergency radiation therapy to the mediastinum in those with severe respiratory.
- Exclusion criteria:
- Patients with superior vena cava syndrome, significant compression of the trachea requiring more than 40% oxygen or having significant dyspnea at normal activity
Exclusion
Key Trial Info
Start Date :
March 1 1993
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2004
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00187122
Start Date
March 1 1993
End Date
June 1 2004
Last Update
April 23 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Jude Children's Research Hospital
Memphis, Tennessee, United States, 38105